Driving reinvestment in R&D for antibiotics and advocating their responsible use

News

Statement on ReAct’s Departure from the DRIVE-AB Consortium

DRIVE-AB regrets that ReAct has decided to leave the DRIVE-AB partnership. We believe that ReAct has contributed positively to the conversations and development of DRIVE-AB’s research. With ReAct leaving, we lose an important voice within the project to represent civil society. DRIVE-AB (www.drive-ab.eu) has been from the start a public-private partnership including 22 partners from large pharmaceutical companies, academia, and civil society, in other words, a contrasting mix of people with different experience, expertise and visions. This is the strength and the originality of the project, but also represents its major challenge. As the project developed, DRIVE-AB has had to adapt to a fast-moving environment due to political...
Read more

Registration Now Open: Final DRIVE-AB Conference

Revitalizing the Antibiotic Pipeline

Stimulating innovation while driving sustainable use and global access 5-6 September 2017, Crowne Plaza, Brussels

Registration for the final DRIVE-AB conference is now open. Aimed at global policy and decision makers, regulatory and public health experts, economists and representatives of the pharmaceutical, medical and civil society communities, the purpose of the conference is to:
  1. communicate the consortium’s final recommendations and
  2. work with stakeholders towards implementing them worldwide.
For more information and to view the programme, please see the conference website. If you are...
Read more

UN Inter-agency Coordination Group on AMR convenes

The Inter-Agency Coordination Group (IACG) on AMR established by the UN Secretary-General met for the first time on the 2nd and 3rd of May. The group, comprised of high-level representatives from relevant UN agencies, individual experts, and other international organizations, is tasked with providing practical guidance on approaches to implement and ensure effective global action to address AMR, including options to improve coordination, fulfill the Global Action Plan on Antimicrobial Resistance, and implement Sustainable Development Goals. The IACG is expected to produce a report to the Secretary-General for the 73rd session of the UN General Assembly. DRIVE-AB partner Otto Cars attended the meeting as an individual expert. Read more

DRIVE-AB Survey on Global Incidence of 4 Drug-Resistant Organisms is Now Available

A DRIVE-AB survey to gather information on the global incidence of infections caused by selected antibiotic-resistant bacteria is now available. The results of this survey will be made available to public health officials and researchers to provide a basis for decision-making regarding the prevention, control, and treatment of infections by drug-resistant organisms. To read more or to complete the survey, please click here.      ...
Read more